These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11791943)

  • 21. Evaluation of a commercial medium for identification of Candida species.
    San-Millán R; Ribacoba L; Pontón J; Quindós G
    Eur J Clin Microbiol Infect Dis; 1996 Feb; 15(2):153-8. PubMed ID: 8801088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An emerging issue of mixed yeast cultures.
    Yang YL; Chu WL; Lin CC; Tsai SH; Chang TP; Lo HJ
    J Microbiol Immunol Infect; 2014 Aug; 47(4):339-44. PubMed ID: 23523053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Identification of yeasts of clinical interest on CHROMagar Candida culture medium.].
    García-Martos P; García-Agudo R; Hernández-Molina JM; Marín P; Tallero E; Mira J
    Rev Iberoam Micol; 1998 Sep; 15(3):131-5. PubMed ID: 18473532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of local clinical Candida isolates using CHROMagar Candida™ as a primary identification method for various Candida species.
    Madhavan P; Jamal F; Chong PP; Ng KP
    Trop Biomed; 2011 Aug; 28(2):269-74. PubMed ID: 22041745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of the new colorimetric VITEK 2 yeast identification card versus the older fluorometric card and of CHROMagar Candida as a source medium with the new card.
    Aubertine CL; Rivera M; Rohan SM; Larone DH
    J Clin Microbiol; 2006 Jan; 44(1):227-8. PubMed ID: 16390976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness and efficacy of CHROMagar Candida medium in clinical specimens.
    Momani OM
    East Mediterr Health J; 2000; 6(5-6):968-78. PubMed ID: 12197356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of CHROMagar Candida for presumptive identification of clinically important Candida species.
    Powell HL; Sand CA; Rennie RP
    Diagn Microbiol Infect Dis; 1998 Nov; 32(3):201-4. PubMed ID: 9884836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yeast identification in routine clinical microbiology laboratory and its clinical relevance.
    Agarwal S; Manchanda V; Verma N; Bhalla P
    Indian J Med Microbiol; 2011; 29(2):172-7. PubMed ID: 21654115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of pigment production by yeast isolates grown on CHROMagar Candida medium.
    Hospenthal DR; Murray CK; Beckius ML; Green JA; Dooley DP
    J Clin Microbiol; 2002 Dec; 40(12):4768-70. PubMed ID: 12454192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the rapid yeast plus panel with the API20C yeast system for identification of clinically significant isolates of Candida species.
    Heelan JS; Sotomayor E; Coon K; D'Arezzo JB
    J Clin Microbiol; 1998 May; 36(5):1443-5. PubMed ID: 9574727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of CHROMagar Candida for rapid screening of clinical specimens for Candida species.
    Willinger B; Manafi M
    Mycoses; 1999 Apr; 42(1-2):61-5. PubMed ID: 10394850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Chromogenic Candida Agar for isolation and presumptive identification of pathogenic yeast species.
    Ghelardi E; Pichierri G; Castagna B; Barnini S; Tavanti A; Campa M
    Clin Microbiol Infect; 2008 Feb; 14(2):141-7. PubMed ID: 17986267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yeast identification in the clinical microbiology laboratory: phenotypical methods.
    Freydiere AM; Guinet R; Boiron P
    Med Mycol; 2001 Feb; 39(1):9-33. PubMed ID: 11270413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures.
    Tan GL; Peterson EM
    J Clin Microbiol; 2005 Apr; 43(4):1727-31. PubMed ID: 15814992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of a new chromogenic medium (Candida ID) for the isolation and presumptive identification of Candida albicans and other medically important yeasts].
    Quindós G; Alonso-Vargas R; Helou S; Arechavala A; Martín-Mazuelos E; Negroni R
    Rev Iberoam Micol; 2001 Mar; 18(1):23-8. PubMed ID: 15482010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid identification of the Candida species from direct blood cultures by CHROMagar Candida.
    Birinci A; Akkurt L; Acuner C; Unlu M; Durupinar B
    J Int Med Res; 2004; 32(5):484-7. PubMed ID: 15458279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a reformulated CHROMagar Candida.
    Jabra-Rizk MA; Brenner TM; Romagnoli M; Baqui AA; Merz WG; Falkler WA; Meiller TF
    J Clin Microbiol; 2001 May; 39(5):2015-6. PubMed ID: 11326038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the new chromogenic medium Candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species.
    Eraso E; Moragues MD; Villar-Vidal M; Sahand IH; González-Gómez N; Pontón J; Quindós G
    J Clin Microbiol; 2006 Sep; 44(9):3340-5. PubMed ID: 16954270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of CHROMagar Candida for genital specimens in the diagnostic laboratory.
    Houang ET; Chu KC; Koehler AP; Cheng AF
    J Clin Pathol; 1997 Jul; 50(7):563-5. PubMed ID: 9306935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of CHROMagar Candida medium for the isolation and direct identification of yeast species from the female genital tract.
    Anson JJ; Allen KD
    Br J Biomed Sci; 1997 Dec; 54(4):237-9. PubMed ID: 9624731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.